CC
SAGE

Corton Capital’s Sage Therapeutics SAGE Stock Holding History

Corton Capital’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-26,025
Closed -$141K – 380
2024
Q4 		$141K Sell
26,025
-2,378
-8% -$14.5K 0.08% 311
2024
Q3 		$205K Buy
28,403
+1,562
+6% +$14.3K 0.1% 370
2024
Q2 		$291K Buy
26,841
+5,909
+28% +$75.7K 0.15% 205
2024
Q1 		$392K Sell
20,932
-2,471
-11% -$57K 0.14% 193
2023
Q4 		$507K Buy
+23,403
New +$464K 0.16% 169

Other funds holding SAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return